New hope for rare cancers: targeted drug enters human trials
Disease control
Recruiting now
This study tests an experimental drug called 3HP-2827 in adults with advanced solid tumors that have specific FGFR2 gene changes. The goal is to find a safe dose and see if the drug can shrink tumors. About 130 participants will take the drug by mouth, and researchers will monito…
Phase: PHASE1, PHASE2 • Sponsor: 3H (Suzhou) Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC